当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Kiyoshi Kanaya*, Shine Abe and Haruo Hanyu
To clarify differences between dementia with Lewy Bodies (DLB) and Alzheimer’s disease (AD) in the actual clinical setting, we studied sites of decreased cerebral blood flow (CBF) in cases of DLB and AD by 99mT-ECD-SPECT imaging using statistical parametric mapping (SPM8). In addition, the drug sensitivity was analyzed by SPM8. Twentyfive cases were classified as DLB with AD (DLB-w) and 8 cases were DLB without AD (DLB-wo). Sites of decreased CBF in the DLB-w group were observed in the posterior cingulate gyrus, bilateral parietotemporal association areas and the occipital lobe, and these sites resembled the pattern of decreased CBF associated with AD. Among the DLBwo cases, decreased CBF was observed in frontal lobe, anterior cingulate gyrus and occipital lobe. In a comparison of sites of decreased CBF prior to treatment between 15 cases in the group exhibiting drug sensitivity and 18 cases in the group not exhibiting drug sensitivity, the drug sensitivity group exhibited more prominent decreases in CBF in the frontal lobe. In summary, 78% of DLB cases were determined to be complicated with DAT based on SPECT imaging, and the pattern of decreased CBF in these cases resembled that of DAT.